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2Abstract
Benzodiazepines are a group of drugs used mainly as sedatives, hypnotics, 
anti-epileptics and muscle relaxants. Consumption is recommended for 2-4 
weeks only (NICE CKS 2013) due to fast onset of dependency and potentially 
distressing withdrawal symptoms (Ashton, 2005; Lader, 2012). Few peer 
review studies have drawn on the user experiences and language to 
appreciate first hand experiences of benzodiazepine withdrawal or 
discontinuation syndrome (Fixsen, 2015). We looked extensively at patient 
stories of benzodiazepine withdrawal and recovery on Internet support sites 
and YouTube. Our analysis indicated that users employ rich metaphors to 
portray the psychologically disturbing and protracted nature of their suffering. 
We identified seven major themes: hell and isolation; anxiety and depression; 
alienation; physical distress; anger and remorse; waves and windows; and 
healing and renewal. By posting success stories, ex-users make known that 
“healing” can be a long, unpredictable process, but distress does lessen and 
recovery can happen.
Keywords: benzodiazepines, dependency, patient narratives, metaphor, 
electronic support groups, distress, recovery.
3Introduction 
Benzodiazepines (also called BZ drugs or “benzos”) are a group of drugs used mainly 
as sedatives, hypnotics, anti-epileptics and muscle relaxants. Commonly used types 
include alprazolam (Xanax), clonazepam (Klonopin), diazepam (Valium), lorazepam 
(Ativan) and tamazepam (Restoril). The class of hypnotics known as “Z drugs” (e.g. 
zaleplon, zolpidem and zopiclone) are considered to have similar addictive qualities 
and side effects (Ford et al., 2014; NICE, 2004). Although not recommended for use 
beyond 2 to 4 weeks (NICE CKS, 2013) due to serious adverse effects (including 
dementia, cancer and increased accident risk (Uzun, Kozumplik, Jakovljevic, & 
Sedic, 2010) and the rapid development of tolerance and withdrawal symptoms 
(Reconnexion, 2010), benzodiazepines continue to be prescribed for months or even 
years (Ford et al., 2014). In the UK there are around 1-1.5 million long-term users 
(APPGITA 2014; Ford, Law, Barjolin, Betterton, & Carnwath, 2014), as well as an 
unknown number of illicit users, and figures are frequently higher in other countries 
(Islam, Conigrave, Day, Nguyen, & Haber, 2014; Neutel, 2005; Rosman, Le Vaillant, 
& Pelletier-Fleury, 2011). Estimates of long term use are highest in studies of the 
elderly (Kurko et al., 2015; Olfson, King, & Schoenbaum, 2014). 
Clinical research into benzodiazepine withdrawal suggests that sufferers can 
experience a range of psychological symptoms (including rebound anxiety, 
depression, insomnia, depersonalization) and bodily symptoms (including pain, 
tension, spasm, tachycardia) which can extend far beyond drug cessation with no 
predictable ending (Ashton, 1991, 2005; Barker, Greenwood, Jackson, & Crowe, 
2005). Very few peer review studies have considered benzodiazepines from the user 
4perspective (Cook, Biyanova, Masci, & Coyne, 2007; Gabe & Lipshitz-Phillips, 
1982) and even fewer have drawn on the language employed by users themselves 
(Fixsen, 2015) to explore first-hand experiences of withdrawal or discontinuation 
syndrome. We conducted a comprehensive review of literature of relevant Internet 
support sites and YouTube videos, investigating benzodiazepine users’ descriptions of 
their withdrawal distress and recovery, then compared these descriptions with 
published literature. After outlining what is known about benzodiazepines use and 
withdrawal, and highlighting socio-political issues surrounding benzodiazepine 
dependency, we investigate Internet user accounts of benzodiazepine withdrawal and 
recovery to better understand their experiences. 
Published user accounts suggest that withdrawal, although differing from 
person-to-person, has the potential to place sufferers in an alien, disconnected, and 
sometimes, hellish world, which is hard describe using everyday parlance (Hobson-
DuPont, 2006; Johns, 2012; Samet, 2013). Our searches indicate that users overcome 
the lack of available language by employing and sharing metaphors to portray the 
psychologically disturbing and protracted nature of their suffering. As they cycle 
between hope and hopelessness, people in withdrawal use blogs and discussion 
threads to examine and discuss the feasibility of issues like “100% healing,” while 
authors of success stories use personal and collective idioms to describe and give 
meaning to their subjective experiences of recovery. By posting their success stories, 
ex-users make known to other users that recovery is possible, but that it its timescale 
is unpredictable and possibly measurable in years. Moving on from this experience is 
nevertheless described as a real possibility and some ex-users liken it to a type of 
“rebirth.”
5Benzodiazepines- the background
Benzodiazepines have an extended history of use within and outside the medical 
sphere. With their range of sedative, anxiolytic, anticonvulsant and muscle relaxant 
actions and their early-on assumed non-addictive nature and low toxicity,   
benzodiazepines initially appeared an ideal medication for a range of common 
conditions (Ashton, 2005). The first benzodiazepine, chlordiazepoxide (Librium), was 
introduced into clinical practice in the 1960’s when it was hailed as a safe and 
effective alternative to existing hypnotics and barbiturates, with less risks of abuse 
and overdose (Licata & Rowlett, 2008). By the late 1970’s, benzodiazepines were 
amongst the most widely dispensed prescription medications in the world. Soon after 
their introduction however, evidence concerning their adverse effects and abuse 
potential began to accumulate (Hallstrom & Lader, 1982; Lader & Petursson, 1981). 
Adverse effects of benzodiazepines are numerous and include impaired 
cognitive and motor faculties (Barker et al., 2005; Bierman et al., 2007), increased 
risk of accidents and increased morbidity including dementia, as well as cancer risks 
(Uzun, Kozumplik, Jakovljević, & Sedić, 2010). Even at regular “therapeutic” doses, 
not only are withdrawal symptoms extremely common, but are severe enough to leave 
some patients involuntarily addicted (Lader, 2012). In 2016 the BMA called for a 
concerted program to support people who wished to come off these addictive 
medications (BMA, 2016). 
Effects and withdrawal
Benzodiazepines appear to exert their anxiolytic, anticonvulsant, muscle-relaxant and 
sedative-hypnotic properties by acting through specific GABA(A) receptor sites 
(GABA being the major inhibitory neurotransmitter in the central nervous system) 
6(Ashton, 2005). GABA(A) sites occur throughout the brain and body, and the nervous 
system rapidly habituates to this artificial GABA booster, thus discontinuation can 
cause considerable mental and physical distress (Tan, Rudolph, & Lüscher, 2011). An 
estimated 20-50% of benzodiazepines users will experience problems withdrawing, 
and in around a third these symptoms are very distressing (BBC Radio 4, 2011). 
Rarely used as the sole drug of abuse (Lader 2012, Ford et al. 2014), the “numbing” 
effects of “benzos” are often sought after by illicit drug users, who subsequently 
become progressively less capable of tolerating their emotions and life stressors 
(Longo & Johnson, 2000). While benzodiazepines can provide temporary relief, over 
time the pathological effects of the dependence can cause a secondary suffering which 
exceeds the original problem (Chen, 2010). Unlike most psychoactive medications 
however, benzodiazepines are equally used for recreational and medicinal purposes 
and the majority of long term benzodiazepine users have become unintentionally 
dependent after medical prescription (Ashton, 2005). Having mental health problems, 
being older, less educated and lonely have been associated with long-term 
prescriptions for benzodiazepines (Zandstra et al. 2004).
Current advice for discontinuing benzodiazepines is to taper the dose 
gradually over a timescale acceptable to the individual (Ashton, 2005; Ford et al., 
2014). In some cases, withdrawing from benzodiazepines can prove relatively 
straightforward, however, particularly for long term users, symptoms of withdrawal 
can be protracted, highly distressing and sometimes incapacitating (Ashton, 2005; 
Lader, 2012). Patients can feel physically ill and suffer from disconcerting symptoms 
including severe panic or extreme hypersensitivity to noise and light. Other 
distressing withdrawal symptoms include depression, insomnia or nightmares, 
hallucinations, suicidal thoughts, tachycardia, muscle tension, tremor and tinnitus, and 
7many more mental and physical problems (Ashton, 2005; Busto et al., 1986; Ford et 
al., 2014; Lader, 2012). Serious effects such as fits, psychosis and death are rare, but 
do occur ( Lader, 2012), especially if discontinuation is abrupt. Unsurprisingly, for 
long-term users the relapse rate is substantial (Morin, Bélanger, Bastien, & Vallières, 
2005). Nevertheless, patients who do withdraw successfully report significant 
improvements in health and wellbeing over the longer term (Ashton, 2005; Vikander, 
Koechling, Borg, Tönne, & Hiltunen, 2010). No medications are specifically 
approved for treating benzodiazepine dependence, although some studies suggest that 
the drug flumazenil can lessen withdrawal symptoms and seizures (Ford et al., 2014). 
Other treatment approaches include switching patients to longer acting non-
benzodiazepines, or where a formal diagnosis of anxiety has been made, prescribing 
adjunctive medications such as antidepressants or antipsychotics (Ashton, 2005).
Benzodiazepine Dependence 
Despite considerable concerns about the overprescribing of BZ/Z drugs, many GPs 
still know little about their withdrawal effects, and they continue to be prescribed 
inappropriately (Sirdifield et al., 2013). The reasons for the continued high dispensing 
rates of benzodiazepines are complex (Ford et al., 2014; Sirdifield et al., 2013). In the 
short term, benzodiazepines have fewer side effects and more rapid anxiolytic effects 
than antidepressants (Price, Cole, & Goodwin, 2009). GPs can feel a sense of 
powerlessness in dealing with psychosocial problems, and with consultation times 
averaging 10 minutes in the UK, prescribing benzodiazepines is easier than 
addressing underlying causes. With inadequate alternatives in the medical armory, 
long-term benzodiazepine prescribing (over six months) is still widespread in many 
countries (Olfson, King and Schoenbaum, 2015).
8A major factor leading to dependency is the relative rapidity with which 
dependency occurs, which can take both physician and patient by surprise. 
Benzodiazepines tolerance and inter-dose withdrawal symptoms can develop within 
months, which, when considered alongside existing symptoms, can make withdrawal 
effects harder to identify. Formerly used to describe uncontrolled drug-seeking 
behavior, the term dependence has been redefined to include the physiological 
adaptation that occurs when medications acting on the central nervous system are 
taken, resulting in rebound symptoms when the medication is abruptly discontinued 
(O’Brien, 2011). Benzodiazepines have been found to produce dependence even in 
low doses in both human and animal studies (Licata & Rowlett, 2008), and 
distinctions between physiological and psychological dependence are blurred 
(Ashton, 2005). Social perceptions of drug use and dependence have been slow to 
change however, and the prevailing public view of drug dependence is as primarily a 
social problem that requires interdiction and law enforcement rather than a health 
problem requiring harm-minimization and treatment (McLellan, Lewis, O’Brien, & 
Kleber, 2000). Users may be blamed for taking drugs in the first place and are 
perceived as having a choice as to whether or not to take them (Lloyd, 2010).
Support during withdrawal
While parallels can be drawn between benzodiazepine withdrawal and other 
psychotropic discontinuation syndromes, withdrawing from benzodiazepines appears 
to be particularly prolonged and distressing. At least one expert has described 
benzodiazepines as more difficult to withdrawal from than heroin (BBC Radio 4, 
2011). A key feature of withdrawal is an exaggerated state of anxiety, in which many 
of the taken for granted aspects of everyday life (such as making a meal, going 
9shopping, talking on the telephone) become objects of dread or are experienced as 
overwhelmingly difficult (Hobson-Dupont, 2006; Johns, 2012; Samet, 2013). Along 
with the psychophysical symptoms of dependency and withdrawal, users face issues 
associated with a contested and debilitating illness that is not only stigmatized (Lloyd, 
2010), but considered suspect by medical professionals (Hobson-Dupont, 2006; 
Pittman, Youngs, & Karle, 2013; Samet, 2013). Patients can feel a sense of anger and 
failure at being placed on the medication in the first place (Price et al., 2009), and/orat 
being unable to withdraw successfully. As benzodiazepine users are often put on 
antidepressants or painkillers (Ashton, 2005), they may face the prospect of side 
effects and discontinuation/withdrawal from other psychoactive drugs. 
Social and psychological support from peers and support staff is an important 
part of drug dependence recovery (Redden, Tracy, & Shafer, 2013; Ridge & Ziebland, 
2006). Clinical studies suggest that people receiving advice and help are more likely 
to succeed in stopping benzodiazepines for good (Ashton, 1994; Morin et al., 2004). 
In practice accessing specialized support is often difficult however, and the number of 
specialist benzodiazepine withdrawal and recovery programs is small (APPGITA, 
2014). In the absence of coordinated help from governments, online benzodiazepine 
self-help groups and forums emerged from the late 1990’s, providing information and 
support to users and their families. With the long-term diminution of users, the 
number of active forums has fallen. Some successful forums, on the other hand, 
continue to expand and attract comments and stories from users and their families 
across the world. Membership to the largest benzodiazepine support forum run by lay 
members, Benzo Buddies (www.benzobuddies.org) grew from 10,000 members in 
2011 to over 18,000 in 2016. YouTube is also a highly popular and growing platform 
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through which users can upload and share home made videos recounting their own 
stories of benzodiazepine use and withdrawal. 
There are good reasons why benzodiazepine users may prefer to utilize online 
communication channels rather than seek out face-to-face help (Tanis, 2008; Yeshua-
katz, 2015). The anonymity of online sites means less risk of social embarrassment 
and people are able to exert more choice over what they say and with whom they 
interact. Health “communities” can develop online, established independent of time 
and geographical space (Douglas et al., 2008). People can connect with others in 
similar circumstances (April et al., 2007; Broom & Tovey, 2008; Hinton, Kurinczuk, 
& Ziebland, 2010) and can learn to better manage long term problems or conditions. 
Posting on YouTube is likely to have different rewards for the posters, such as 
gaining credibility, becoming a spokesperson for a stigmatized group and/or attaining 
hero status (Fixsen, 2015).  In this study, we investigate user posts on these Internet 
support sites and YouTube videos, to better understand and interpret their experiences 
of benzodiazepine withdrawal and recovery. 
Methodology
While critics of narrative enquiry allege a naive approach to illness (Atkinson & 
Delamont, 2006), patient stories can provide fundamental insights into lived 
experiences, and can help “plunge” the researcher into the subjects’ inner worlds of 
participants, thus capturing deeper essences of suffering while providing analytical 
clues about amelioration of distress and promotion of recovery (Franzosi, 1998). To 
construct our collective account we used a narrative approach, investigating the 
metaphors and language expressed by benzodiazepine users themselves. We, Alison 
Fixsen (first author) and Damien Ridge (second author) looked at data within a wide 
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range of publically available online accounts of benzodiazepine use and withdrawal. 
In addition, we employed autobiographical literature, including Alison’s personal use 
and recovery from benzodiazepines, for comparative purposes (Fixsen, 2015). In 
selecting posts, we made no distinction between prescribed and illicit use, as our 
interest was on the lived experience of benzodiazepine withdrawal.
From May 2013- December 2014, Alison (while in personal withdrawal from 
benzodiazepines) had an online alias and an Internet presence on the Benzo Buddies 
site. User data viewed at this time is excluded from this study (see ethics section 
below), but nevertheless provided valuable “insider” cultural knowledge of the 
workings of such support sites. In the second phase (January-September 2014), we 
conducted over 500 general and focused searches of anonymous online BZ support 
forums and BZ user sites for personal accounts of withdrawal and recovery. From 
January to September 2014, Alison carried out over 800 searches of benzodiazepine 
related websites and webpages, using the search terms benzodiazepines, “benzos” and 
“tranquillizers.” From September 2014- January 2017, we focused on the following 
search terms: “benzodiazepine/ benzo withdrawal,”‘ benzo “hell,” “recovery” and  
“healing,” and “benzodiazepine/ benzo success stories.”
To ensure that as wide a sample of viewpoints on benzodiazepine withdrawal 
and distress was included, support sites with active and inactive forums (but with 
personal user stories), popular Internet blogs, and videos posted on YouTube, were all 
reviewed. On YouTube, we found over 14,000 videos (26/5/2017) under “benzo 
withdrawal,” most of them describing personal stories, thus indicating the popularity 
of YouTube as a platform for benzodiazepine users. 10,100 videos were listed under 
“benzo hell,” (the most frequently viewed having over 161,000 views), 2,260 under 
“benzo nightmare,” 3,600 under “benzo anxiety” and 2,230 on “benzo recovery.” 
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While it was not possible to view all these videos due to time constraints, Alison 
reviewed 300 of the most popular videos.
For ethical reasons, and to make the enormous amount of online data more 
manageable, we excluded: webpages only available for viewing with a user password; 
non-English sites; and information sites lacking facilities for people to post personal 
messages or narratives of benzodiazepine use and withdrawal. As the largest and most 
active benzodiazepine support site on the Internet, Benzo Buddies was the most 
frequently searched site. There are also a number of benzodiazepine sites (such as 
benzo.org.uk), which no longer have active forums, but can still be publically viewed. 
Details of the main searches conducted September 2014-16 are described in Table 
one. 
(Insert Table one: online searches about here).
Analysis
We analyzed data using a stage-by-stage process. Careful attention was paid to the 
actual language and phrases describing user experiences, a notable feature being the 
use of strong and vivid metaphors. More than mere linguistic devices, metaphors are 
important vehicles for understanding our physical, social and inner world (Schmitt, 
2005) and can transmit and evoke meanings beyond that of ordinary language, 
assisting the reader/listener to connect emotionally to the experiences described 
(Patton, 1990). Other studies have successfully employed metaphor analysis in the 
context of drug use and recovery (Redden et al., 2013) and to interpret distress 
(Kantrowitz-Gordon & Vandermause, 2016). Metaphor has been accused of 
projecting the researcher’s views, distorting findings (Carpenter, 2008) or leading to 
loss of meaningful findings (Sandelowski, 1998). Mindful of these criticisms, we 
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searched extensively for user accounts and cross-referenced them with clinical models 
of benzodiazepine withdrawal described in the literature (e.g. Ford et al., 2014).
During the early stage of our research (January-September 2014), Alison 
collected and examined samples of patient writing from each of these sites, noting any 
characteristic words or phrases appearing repeatedly. Large extracts of written 
narrative accounts of benzodiazepine withdrawal and recovery on user sites were cut 
and pasted into Word to aid analysis. Words or expressions associated with 
benzodiazepine withdrawal and recovery were highlighted and cross-coded according 
to category headings. We then compared concepts and categories further, noting 
recurring themes, discussing and debating initial results. Alison then re-read these 
accounts, and conducted a second more focused Internet search (September 14- 
January 2017) based on broad themes identified in the first phase. Selecting and 
honing themes was an interpretative process, with the meaning of the theme and its 
indicators prioritized, inferred, interpreted, or signaled, rather than necessarily being 
directly present (Morse, 2015).
 We then developed a final coding system (e.g. hellish, alien, healing) to apply 
across the data, and manually coded them under themed headings. To check validity 
of online accounts of withdrawal we compared them with descriptions used in 
unpublished autobiographies of benzodiazepine users (Hobson-Dupont, 2006; Johns, 
2012; Samet, 2013) and in the clinical literature. In addition, scenarios lying outside 
our experience and our “model withdrawal scenario,” such as users with no 
symptoms, users who do not wish to discontinue, or users who went back on 
benzodiazepines, were also examined. Through interpreting the idioms and metaphors 
employed by all users, we were able to construct what we regard as a relatively 
accurate picture of distress and recovery during benzodiazepine withdrawal.
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Ethical issues
We received ethical approval from our institutional committee, on the agreement that 
no real names were used. To address the new ethical and legal issues and other 
problems associated with conducting online research (Convery & Cox, 2012), the 
Associate of Internet Researchers (AoIR) advocates guidelines to Internet research so 
that ethical research can remain flexible, be responsive to diverse contexts, and be 
adaptable to continually changing technologies (AoIR, 2012). To protect privacy we 
have used only brief, anonymous accounts of benzodiazepine withdrawal and limited 
these to our topic area of benzodiazepine withdrawal and recovery. Informed consent 
was not asked or obtained, as all data examined in this project constituted open 
messages, which anyone could access via their own computer. In addition we 
considered issues around the legitimacy and reliability of data collected from online 
sites, weighing these against the advantages of the naturalistic and spontaneous nature 
of Internet posts. Our motivation in conducting the current research is to develop 
better conceptual frameworks for the personal experiences of users and ex-users, 
based on publically available data, so we do not consider there to be a conflict of 
interest. Our searches and comparisons have been rigorous and we have constantly 
sought to test out concepts emerging from our readings from one source with other 
sources. 
Findings
As evidenced by the millions of hits on YouTube and benzo support sites, users going 
through benzodiazepine withdrawal frequently search online for stories about others 
who have had, or are having, similar experiences. Users want to find accounts that 
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resonate, and many accounts are geared towards reassuring users that they are not 
alone, e.g. “I was there too. I plan on completely recovering from this, and so will 
you.” 
Hell and isolation
While some users and ex-users admit to being recreational or multi-drug users, others 
describe how they found themselves inadvertently dependent on prescribed 
benzodiazepines and suffering from their effects in relatively short spaces of time; 
e.g., “If someone told me about the hell I would have to endure a little more than a 
year ago, after being handed a couple of little innocently enough looking white pills 
from one careless medical doctor, I would just think he’s having a seriously bad 
joke.” For people who find themselves in a state of benzodiazepine dependency, 
withdrawal can be a protracted and distressing experience. After prolonged use or a 
too rapid withdrawal (such as in a detox clinic) symptoms can be particularly 
harrowing. Users and ex-users employ a variety of idioms to describe the hellish 
quality of acute withdrawal; the “deep dark unmentionable”; ”pure hell”; “my 
invisible hell;” as if “someone ripped your soul out of your body and left you with 
just a shell of a person.” YouTube videos, mostly personal stories of benzodiazepine 
users, reference hell, choosing video titles such as “I’m walking out of hell,” and 
sounding a warning to others to “Never abuse this drug. Never take it as prescribed. 
My life is hell.” 
Anxiety and depression
Heightened or rebound anxiety is a common symptom of withdrawal (Hulse et al., 
2012; Lader, 1994) frequently described by users on Internet sites. One user describes 
16
it as a “primal feeling that you’re about to be attacked by a lion; you’re about to be 
killed”; another as a constant sense of dread and foreboding that leaves them “hidden 
from the world, stricken with panic and fear.” For long-term users, reducing their 
dosage slowly over time, the greatest fear can be attached to taking the final dose 
when the time comes to “jump off” (discontinue benzodiazepines completely). 
Depression is also a commonly discussed side effect of withdrawal, which for some 
people can be profound and protracted; “I can see why people kill themselves feeling 
like this. I've only been taking (benzodiazepines) for a few months, and when I've 
taken psych drugs for months, I've not found the withdrawal too bad, but this is just 
awful.” With the depression can come such a sense of hopelessness and despair that it 
many be “impossible to ever be the same again.” Users express a sense of numbness 
and separation of self; “my emotions are completely flat . . . No joy, happiness, or 
even normal, healthy sadness.” 
Alienation
De-realization, dissociation and cognitive impairment are well documented symptoms 
of benzodiazepine withdrawal (Ashton, 2011). User accounts generally describe a 
spaced out, disconnected dreamlike state in which cognitive functioning is impaired, 
senses distorted in disturbing ways, and normality replaced by a sense of 
otherworldliness. Users also describe a host of perceptual and sensory distortions, 
leading to an altered reality, which is “dreamlike” yet “nightmarish”; “like being a 
zombie”; and ”in a bad dream that I couldn’t waken up from:”
It felt like I was watching the world through a distorted lens, objects looked 
like they were moving or floating a little, and also while talking to another 
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person, I knew they were real, but felt I was imagining them or watching them 
through a weird screen. 
Time and time again, users describe perceptions of being confined to an alien 
landscape. Metaphors about being trapped, stuck or imprisoned were used to describe 
withdrawal. One anonymous user describes benzodiazepine withdrawal as “like being 
locked in jail . . . and having the jailer walk by rattling his keys” or “like being a 
prisoner in a sick brain.” Another person said it was as if other people “lived in a 
different world and we were separated by a transparent screen with distortions in it . . 
. weird and scary.” Above all, users describe the “benzo” state and withdrawal as a 
strange, isolating experience; “It was like I was speaking a different language 
whenever I tried to speak about it to anyone.” The moment-to-moment awareness of 
one’s own suffering and the “endless looping existential intrusive thought(s)” 
accompanying benzodiazepine withdrawal can create an on-going existential distress. 
As one user expresses it; “what is the meaning in all this suffering . . . I am stretched 
to my limit with this ongoing trauma. Really struggling to see any possible silver 
lining.”
Physical distress
Symptoms of benzodiazepine withdrawal can be physically as well as psychologically 
painful or distressing; e.g. “vision went wacky again yesterday which scares me” ; 
“I’m extremely weak, chills, sweats, bodily pains (following Xanax withdrawal).” 
The physical sensations accompanying withdrawal are compared to forms of torture 
or hell, and metaphors used to describe them include acute burning, wildfire, acid, 
electricity, knifelike pain, crushing and so on; e.g.  “excruciating burning sensations 
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in all the muscles of my body. Sometimes I just STAND STILL AND BURN!” ; 
“gas, pain and diarrhea . . . electric feeling in my heart and every beat was amplified 
torture . . . I was too ill to stand . . . agony.”
Acute and heightened sensitivity to outside stimuli and events is a well-documented 
feature of benzodiazepine withdrawal; “The slightest stress . . . can easily throw me 
into confusion and ramp up sxs [symptoms]. We are just very sensitive right now.” 
Many users experience a profound state of exhaustion, often linked to chronic 
insomnia, one describing it as a “mean beast accompanying benzo withdrawal.”  
Anger and remorse
Even though users can feel completely immersed in their psychological and physical 
suffering, a sense of their experience being chemically induced and shared by others 
can help people to maintain to sense of selfhood separate and distinct from their 
harrowing experiences. On Internet blogs, people use expressions such as having a 
“chemical lobotomy,” and a “poisonous little whore of a pill” to describe the 
overpowering effect of benzodiazepines. Benzodiazepine users on Internet posts 
frequently express remorse at taking the pills in the first place, but also direct 
disappointment and anger at the professionals who they feel have failed them e.g., 
“Why does nothing happen to the psychiatrists who mis-prescribe these drugs 
indefinitely and who give no indication that the drugs are addictive? I don't think 
anything could be done. Are there any standards or rules against it?”
Waves and windows
19
Jumping from (finally stopping) benzodiazepines is rarely the end of the story. 
Emerging from benzodiazepine withdrawal can be a slow and uneven process, with 
ups and downs following every dose reduction. The drawn-out nature of a “safe 
taper” (reducing medication very gradually) can feel tedious and difficult for users:
I'm 10 months out from a horrific c/t (cold turkey) w/d (withdrawal). I 
constantly (like ALL day) contemplate life, my existence, my death, 
generations that have been before . . . These thoughts make me shake and 
consume me with fear . . . Do they really ever stop? 
Classically, there is a “roller coaster” quality to withdrawal, with exacerbations 
(waves) and ameliorations (windows) occurring apparently randomly, mimicking or 
exaggerating an individual’s pre-existing conditions. As they cycle between hope and 
hopelessness, people in withdrawal use blogs and discussion threads to share and 
discuss the existential questions concerning their suffering and the feasibility of  
“100% healing.” Questions such as “will I ever be my old self again?” are met by 
reassurances that “healing does happen!!” yet symptoms can take months or years to 
completely abate. 
Healing
During the difficult process of recovery, Internet users offer each other support, 
encouragement and self-help tips; “Listen to your body and adjust your taper rate to 
suit your individual tolerance. Learn non-drug techniques to help you deal with your 
underlying issues . . . meditation, yoga etc.”  One coping strategy is to accept the on-
going suffering and to have faith that; “HEALING DOES HAPPEN . . . That’s the 
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words you need to have Faith with.” Users and ex-users urge each to “keep in mind 
the real healing comes after you jump, when you are no longer feeding the beast.” 
Those who do make it through the withdrawal journey, and “turn their backs on the 
pills” often express a sense of triumph, and feel compelled to share their successful, 
and at times heroically constructed story with others. Going cold turkey (c/t) or 
quitting benzodiazepines abruptly can be dangerous, and is not recommended (NICE, 
2013). Internet posts on cold turkey suggest that plenty of users (through ignorance, 
poor advice or choice), have stopped in this way, yet the sheer hell of surviving a 
“c/t” can attract some online admiration; “To my c/t warriors!!! You are my heroes. 
This is the hardest test- this is walking through fire. And we're DOING IT!!! ” 
Nevertheless, quitting benzodiazepines can prove too difficult for users; “Failed on 
my last taper because I underestimated how difficult it would be.  I also was 
hospitalized when I tried cold turkey.” 
Renewal 
Inevitably, many people in recovery wish to put their troubling experiences behind 
them and stop posting on support forums. Other people remain active members or 
become site moderators, using their acquired understanding to reassure, educate and 
inspire new and existing members. Those who do succeed and go through recovery 
write encouraging messages to others not to give up hope, even if they need more 
than one attempt at withdrawal: “This was my third time trying to get off  . . . you can 
always try again.” Success stories from beyond withdrawal spread the hopeful 
message that life after “benzos” can be better than ever; “It has been 22 months and 
I’m like new.” After the numbing and disturbing effects of benzodiazepines, recovery 
or “healing” can be a deep experience, likened to a spiritual rebirth by some; 
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“Yesterday . . . was my first benzo free day in over six years! A time of rebirth!!! . . . 
Wish me luck. I'm on my way.”  
Discussion
People who post on YouTube or benzodiazepine support sites represent a small 
proportion of benzodiazepine users worldwide. What users have to say about their 
experiences however is of considerable importance to researchers and practitioners 
wishing to understand benzodiazepine withdrawal. As with other experiences outside 
the “normal” frame of reference, the distress associated with benzodiazepine 
withdrawal may be impossible to fully describe or imagine, even with the use of 
metaphors, unless it has been experienced for oneself (Johns, 2012; Hobson-Dupont 
2006). We identified seven major themes of user stories: hell and isolation; anxiety 
and depression; alienation; physical distress; anger and remorse; waves and windows; 
and healing and renewal. From these accounts we interpret the “essence” of 
benzodiazepine withdrawal as feeling stuck, trapped or imprisoned in a hell-like 
dimension, separated from the “normal world” and people around you. More of a 
roller coaster than a state, benzodiazepine withdrawal is punctuated by symptom 
changes and fluctuations that can test the sufferer on a daily basis. Nevertheless, there 
are increasing glimpses of wellbeing as withdrawal progresses. As such, a common 
online model for user withdrawal involves users trying to step out of their experience 
and look at it for what it is, that symptoms are chemically induced; that withdrawal is 
hard, isolating and can be prolonged; but that others have been through this “walk 
through fire” and are there to encourage and support you. Healing and recovery is 
portrayed as a gradual process, but with it can come a sense of achievement and even 
rebirth.
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To check the validity of our interpretations we cross referenced and compared 
these Internet accounts with professional accounts (Ashton, 1991, 2005; Lader, Tylee, 
& Donoghue, 2009; Reconnexion, 2010). We believe our definition of “benzo 
distress” and recovery encompasses what many users describe as central to their 
experiences. Not all users experience symptoms and for some withdrawal symptoms 
are mild or short lived. Those who suffer most are often long term users or users who 
stop benzodiazepines abruptly. Those posting stories are more likely to have 
experienced particularly disconcerting symptoms, while a high percentage of users 
fail to complete the first taper or reinstate (restart) benzodiazepine use after doing so 
(Pittman et al., 2013). 
The role of benzodiazepine support forums and videos
On-line health support groups are part of a growing body of lay communication 
systems, which challenge the former hegemony of expert-based information systems. 
Their positive impact on healthcare has been widely examined (Berger, Wagner, & 
Baker, 2005; Broom, 2005; Ziebland et al., 2004), including as a source of lay 
knowledge (Broom, 2005; Hardey, 1999) in relation to patient empowerment (Mo & 
Coulson, 2014; van Uden-Kraan et al., 2008). Their relationship with the mainstream 
medical establishment is complex as some forums and blogs offer information which 
could be viewed as inaccurate, risky or subversive (Gavin, Rodham, & Poyer, 2008; 
Mo & Coulson, 2014). The reliability of YouTube as an information source been 
questioned (Morahan-Martin, 2004) and some of the videos on benzodiazepine 






Our study indicates that during and after benzodiazepine withdrawal, people 
turn to forums and seek reassurance, advice and support from other users, sometimes 
in a state of extreme distress and anxiety. Becoming dependent on benzodiazepines 
can impact significantly on a persons’ life, including distorting the persons’ view of 
themselves. Studies of drug users suggest that people reconstruct self-identity as they 
move from being drug-dependent to being drug-free (Redden et al., 2013). Long-term 
users, or anyone experiencing problems coming off “benzos” may find it hard to 
imagine an identity beyond the drugs, and like other marginalized groups may feel 
stigmatized and unable to articulate their particular needs and concerns within the 
dominant medical culture (Orbe, 1998). Despite their limitations, Internet sites like 
YouTube provide users with an alternative forum from which they can express their 
particular form of distress, exchange stories and tips, and celebrate their success with 
others. In a society that broadly disapproves of drug dependence, benzodiazepine 
users can, via their virtual platforms make contact with a global “benzo” community 
and share stories with sympathetic others who may be in a position to advise and 
support them or to learn from them (Fixsen, 2015). Those who recover can hold 
themselves up as real life examples or role models for other users, potentially 
extending our understanding of psychophysical distress and healing (Spermon, 
Darlington, & Gibney, 2013). By communicating their stories, benzodiazepine users 
give meaning and legitimacy to their world-view (Frank, 2013) and in the process 
promote better social recognition of their suffering. In this way, isolated individuals 
find a “shared voice,” and language and can benefit from a sense of belonging to a 
peer (co-) community (Lin & Huang, 2013).
Despite general warnings from the medical and other professions and drug 
regulatory bodies that long-term use is unjustified both in terms of efficacy and the 
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risks of long-term usage including dependence, long-term prescription of 
benzodiazepines continue (Ford et al., 2014). Unlike most studies of side and 
withdrawal effects, we have made no distinction in distinction in our analysis between 
prescribed and illicit use, as our interest lies with the lived experience of 
benzodiazepine withdrawal. This is not to suggest that the two groups of users do not 
face distinct psychosocial issues, but to reinforce the unavoidable embodied and 
mental nature of benzodiazepine withdrawal for all those who must go through it. As 
our study suggests, the distress associated with benzodiazepine dependence and 
withdrawal can be considerable and is regularly underestimated by practitioners who 
prescribe them (Sirdifield et al., 2013). Clinical studies suggest that people who taper 
slowly and receive psychological support are more likely to succeed in stopping 
benzodiazepines for good (Ashton, 2005; Morin et al., 2004), yet specialized NHS 
support for benzodiazepine withdrawal remains minimal, with local support groups 
struggling for adequate funding (APPGITA, 2014). In the absence of easily 
accessible, free or affordable withdrawal and recovery programs it seems likely that 
people will continue to turn to Internet forums for reassurance, advice and support 
during and after withdrawal. 
Conclusions 
In this article, we have drawn on patient narratives in the literature and on Internet 
sites to interpret the nature of benzodiazepine withdrawal, and the distress 
accompanying it, from the user perspective. The experience of benzodiazepine 
withdrawal is uniquely personal yet shared with a global community. The results in 
this paper can only represent a proportion of benzodiazepine user stories and 
experiences. We have focused on the imagery and metaphorical interpretations of 
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withdrawal, as brought to life through text and spoken word, to interpret the collective 
experience of benzodiazepine distress and recovery. Our findings indicate that 
benzodiazepine withdrawal can, according to many user accounts, be a harrowing and 
distressing experience, that can feel alien, hellish and unending to the sufferer. As an 
all-encompassing yet socially invisible experience, it is made socially real through 
Internet forums.
There are a number of limitations to our study. The amount of narrative 
information on benzodiazepine discontinuation posted on the Internet is immense and 
we were able to examine only a selection of this material. In addition, our 
methodology was qualitative and interpretative, thus any conclusions we make are 
offered tentatively. Further, broader studies of user accounts are required which 
provide insights into what it is like to undertake and complete benzodiazepine 
withdrawal.
We believe, nevertheless, that exploring user metaphors in this way has 
allowed us to examine “benzo” withdrawal and recovery from a user-centred 
perspective, which can complement existing professional models of BZ 
discontinuation (Ashton, 2005; Ford et al., 2014; Reconnexion, 2010); help to 
distinguish these phenomena from other psychologically and drug induced states, 
withdrawal or syndromes, and is therefore of considerable value to practitioners and 
researchers. Importantly, models arising directly from consumer/patient experience 
have the potential to influence and change attitudes to complex medico-social 
problems and can lead to the introduction of new treatments and support strategies 
that align more closely with the experiences and day to day needs of the cohort under 
consideration. 
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